Navigation Links
Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results
Date:11/14/2013

NEW YORK, Nov. 14, 2013 /PRNewswire/ -- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases such as primary biliary cirrhosis, today reported financial results for the three and nine months ended September 30, 2013 and announced presentations at upcoming investor conferences.

Third Quarter 2013 Financial ResultsResults of OperationsNine Months Ended September 30, 2013

For the nine months ended September 30, 2013, Intercept reported a net loss of $55.4 million, or $3.15 per share, compared to a net loss of $15.5 million, or $4.64 per share, for the nine months ended September 30, 2012. The $39.9 million increase in net loss was primarily due to the increase in the non-cash charges related to the periodic revaluation of warrant liability of $29.6 million, which was primarily caused by the increase in the market price of Intercept's common stock, and an increase in non-cash stock-based compensation of $5.2 million.

Licensing revenue decreased by $825,000 to $1.2 million for the nine months ended September 30, 2013, compared to $2.0 million for the corresponding period of the prior year, because the up-front payment related to the Servier collaboration was fully amortized as of the third quarter of 2012, and therefore no amortized revenue related to this upfront payment was recognized in 2013.

Research and development expenses increased to $18.4 million for the nine months ended September 30, 2013 from $11.4 million for the corresponding period of the prior year, primarily as a result of increased activities in Intercept's development program for its product candidate, obeticholic acid (OCA).  The increase in R&D expense compared to the corresp
'/>"/>

SOURCE Intercept Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Intercept Pharmaceuticals Closes $30 Million Series C Financing
2. Intercept Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
3. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
4. Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock
5. Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference
7. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
8. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
11. Icahn Issues Statement Regarding Amylin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Service Strategies ... today announced that Fresenius Kabi, a global healthcare ... for infusion, transfusion and clinical nutrition, has achieved ... Performance (SCP) Standards for the seventh consecutive ... service effectiveness based upon a stringent set of ...
(Date:5/28/2015)... 2015 The global mannequin-based simulation ... analysis and forecast of revenue. This market was valued ... reach $1,177.8 million by 2019, at a CAGR of ... the TOC of Mannequin-Based Simulation Market for an in-depth ... of various tables and figures. http://www.micromarketmonitor.com/market-report/mannequin-based-simulation-reports-5911916854.html ...
(Date:5/28/2015)... YORK, Pa. , May 28, 2015  Unilife Corporation ... its Chairman and CEO, Alan Shortall , will present ... New York at 3:00 p.m. ET on Monday, ... be broadcast over the Internet as a "live" listen only ... archive of the event will also be available for those ...
Breaking Medicine Technology:Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 2Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 3Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 3
... Mylan Inc. (Nasdaq: MYL ) today ... applicable to its 6.50% Mandatory Convertible Preferred Stock (the ... of the company effective as of November 15, 2010. ... provisions of the company,s Amended and Restated Articles of ...
... Mass., Nov. 10, 2010 Hologic, Inc. (Nasdaq: ... participate in the following conferences: Rob Cascella, ... J.P. Morgan SMid Conference in New York City on ... parties are invited to listen to the live audio ...
Cached Medicine Technology:Hologic to Participate in Three Investor Conferences 2
(Date:5/28/2015)... Vancouver, BC (PRWEB) May 28, 2015 ... iData Research ( http://www.idataresearch.com ), the shoulder reconstruction ... the orthopedic small bone & joint market in ... of shoulder arthroplasty procedures in the U.S. due ... as improved device technology resulting in greater patient ...
(Date:5/28/2015)... Houston, Tx (PRWEB) May 28, 2015 ... and decision support company, announces that it will ... and pharmacogenomics (PGx) testing at the annual American ... weekend. , Next-generation sequencing evaluates the DNA in ... The DNA is analyzed for key changes or ...
(Date:5/28/2015)... Hexagon Geospatial is pleased to announce that ... spatial data and mapping services, is using Hexagon Geospatial ... for urban change assessments in Bernalillo County, New Mexico. ... Data Division implemented a countywide approach to generating pixel-resolution ... a variety of different digital aerial camera systems, BHI ...
(Date:5/28/2015)... May 28, 2015 Optimity Advisors ... implementing innovative models of care for healthcare organizations ... alternative reimbursements and help operationalize contracting and engagement ... unveils a bi-weekly series of seven “ OrangePapers” ... Based Contracting. Optimity is a strategy, operations and ...
(Date:5/28/2015)... Sacramento, PA (PRWEB) May 28, 2015 ... wishes and adventures. Each item on the ... absolutely impossible events, experiences and tasks that the owner ... is no right or wrong when it comes to ... starting a business, writing poems, publishing a book, seeing ...
Breaking Medicine News(10 mins):Health News:DePuy Synthes and Biomet Lead Fastest Growing U.S. Shoulder Reconstruction Device Market 2Health News:DePuy Synthes and Biomet Lead Fastest Growing U.S. Shoulder Reconstruction Device Market 3Health News:CompanionDx® Launches Integrated Genomic Solution at ASCO Meeting 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2
... February 22, 2011 The McKesson Foundation today ... grants as part of its Mobilizing for Healthsm initiative ... diseases through the use of mobile-phone technology. The Mobilizing ... support studies on diabetes care and management at six ...
... February 21, 2011 New research shows that ... and stroke risks may not have gotten approval from ... effects of fluid retention had been better understood. Fluid ... and strokes of medications such as Vioxx, Bextra, and ...
... using a convenient blood glucose test for diagnosing diabetes and ... Mott Children,s Hospital shows it,s not the best way to ... has become the preferred way to diagnose diabetes among the ... The simple test measures longer-term blood sugar levels -- without ...
... French . An electronic health record system ... more must be done to speed up the implementation of this ... in place effectively, doctors and front line health care workers and ... are the findings of an innovative new study assessing the effectiveness ...
... , TUESDAY, Feb. 22 (HealthDay News) -- People with ... others to develop shingles, according to a new study. ... in a painful rash with lesions. Though it was ... an increased risk for the condition, the researchers of the ...
... , TUESDAY, Feb. 22 (HealthDay News) -- Ignition devices ... the number of new arrests of drivers who were ... The team with the U.S. Centers for Disease Control ... ignition interlocks, devices that prevent someone from operating a ...
Cached Medicine News:Health News:McKesson Foundation awards $1.3 million in 6 Mobilizing for Health Research grants 2Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 2Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 3Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 4Health News:Convenient blood test not as effective for diagnosing diabetes in children 2Health News:E-health must be a priority, researchers say 2Health News:Car Ignition 'Interlocks' Thwart Alcohol-Impaired Drivers 2
Puntenney curved forceps, curved, smooth 10 mm platforms....
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Curved, very delicate, smooth jaws with platforms., ,Straight, very delicate, smooth jaws with platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Medicine Products: